The global biosimilars market was valued at $15.9 billion in 2021, and is projected to reach $143.6 billion by 2031, growing at a CAGR of 24.7% from 2022 to 2031.
Report Code : A00573 | Pages : 242 | Category : Life Sciences
The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025.
Report Code : A02397 | Pages : 171 | Category : Life Sciences
The global intravenous immunoglobulin market was valued at $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 ...
Report Code : A00235 | Pages : 202 | Category : Life Sciences
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...
Report Code : A03806 | Pages : 231 | Category : Life Sciences
The global ulcerative colitis market was valued at $6.2 billion in 2020, and is projected to reach $10.8 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.
Report Code : A03620 | Pages : 225 | Category : Life Sciences
The global natural killer cells therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026.
Report Code : A01802 | Pages : 217 | Category : Life Sciences
Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. In addition, they are used to cure several diseases such as strep throat, urinary tract ...
Report Code : A04710 | Pages : 282 | Category : Life Sciences
The global pulmonary arterial hypertension treatment market was valued at $7,177.81 million in 2021, and is projected to reach $11,968.60 million by 2031, growing at a CAGR of 5.2% from 2021 to 2031.
Report Code : A05105 | Pages : 335 | Category : Life Sciences
The global lysosomal disease treatment market was valued at $7.6 billion in 2021, and is projected to reach $14.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.
Report Code : A05290 | Pages : 319 | Category : Life Sciences
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02321 | Pages : 188 | Category : Life Sciences
The global enzymes market was valued at $5.8 billion in 2021, and is projected to reach $10.2 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.
Report Code : A00579 | Pages : 350 | Category : Life Sciences
The global antimalarial drugs market accounted for $711,360 thousand in 2018 and is expected to reach $1,019,396 thousand by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02427 | Pages : 193 | Category : Life Sciences
The global orthobiologics market was valued at $4,870 million in 2017 and is projected to reach $6,870 million by 2025, registering a CAGR of 4.3% from 2018 to 2025.
Report Code : A00703 | Pages : 283 | Category : Life Sciences
Global filgrastim market was valued at $ 562.50 million in 2020 and is projected to reach $745.90 million by 2030 registering a CAGR of 2.80% from 2021 to 2030.
Report Code : A03303 | Pages : 193 | Category : Life Sciences
The global antifibrinolytic drugs market was valued at $13,593 million in 2018 and is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026.
Report Code : A05914 | Pages : 165 | Category : Life Sciences
The global BCG vaccine market was valued at $46,637.5 thousands in 2020, and is projected to reach $74,269.55 thousands by 2030, registering a CAGR of 4.8% from 2021 to 2030.
Report Code : A04070 | Pages : 165 | Category : Life Sciences
The global dermatologicals market size was valued at $19,974.3 million in 2020, and is projected to reach $59,309.3 million by 2030, registering a CAGR of 11.5% from 2021 ...
Report Code : A03463 | Pages : 262 | Category : Life Sciences
The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.
Report Code : A03330 | Pages : 293 | Category : Life Sciences
The global specialty enzymes market was valued at $1.2 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Report Code : A00575 | Pages : 245 | Category : Life Sciences
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A05945 | Pages : 243 | Category : Life Sciences
The irritable bowel syndrome treatment market size was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026.
Report Code : A05948 | Pages : 250 | Category : Life Sciences
The global actinic keratosis treatment market was valued at $1,117 million in 2018, and is projected to reach $1,558 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.
Report Code : A05989 | Pages : 235 | Category : Life Sciences
The global male hypogonadism market was valued at $3.1 billion in 2020, and is projected to reach $5.1 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030.
Report Code : A01544 | Pages : 150 | Category : Life Sciences
The global meningococcal vaccine market size was valued at $1,935.5 million in 2018, and is projected to reach $4,192.6 million by 2026, registering a CAGR of 9.5% from ...
Report Code : A00240 | Pages : 197 | Category : Life Sciences
The global heparin market size was valued at $6,535 million in 2020, and is projected to reach $11,015 million by 2028, registering a CAGR of 6.6% from 2021 to 2028.
Report Code : A06186 | Pages : 221 | Category : Life Sciences
